Triazole-Based Compound as a Candidate To Develop Novel Medicines To Treat Toxoplasmosis
Date
2014Author
Dzitko, Katarzyna
Paneth, Agata
Plech, Tomasz
Pawełczyk, Jakub
Węglińska, Lidia
Paneth, Piotr
Metadata
Show full item recordAbstract
This article reports anti-Toxoplasma gondii activity of 3-(thiophen-2-yl)-1,2,4-triazole-5-thione. The compound displayed significant and reproducible antiparasitic effects at nontoxic concentrations for the host cells, with an experimentally determined
50% inhibitory concentration (IC50) at least 30 times better than that of the known chemotherapeutic agent sulfadiazine. Purine nucleoside phosphorylase was defined as the probable target for anti-Toxoplasma activity of the tested compound. These results
provide the foundation for future work to develop a new class of medicines to better treat toxoplasmosis.
Collections
- Artykuły (WCh) [128]